StimCell Enegetics

StimCell Enegetics FCF Yield

The Free Cash Flow Yield of StimCell Enegetics (STME) as of Oct 22, 2026 is -4.98 %. In the previous year, Free Cash Flow Yield was -2.26 % — a change of 120.40% (lower).

FCF Yield

-4.98 %

YoY

120.40%

Last updated:

Free Cash Flow Yield of StimCell Enegetics is 2026 -4.98 % . Free Cash Flow Yield of StimCell Enegetics was 2025 -2.26 % . It decreases by 120.40% lower compared to the previous year.

The StimCell Enegetics FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
-4.94 USD
Jan 1, 2020
-14.81 USD
Jan 1, 2021
-8.97 USD
Jan 1, 2022
-7.19 USD
Jan 1, 2023
-4.34 USD
Jan 1, 2024
-2.33 USD
Jan 1, 2025
-2.26 USD
Jan 1, 2026
-4.98 USD
The StimCell Enegetics FCF Yield history
YEARFCF YieldYoY
-4.98 %+120.40%
-2.26 %-2.95%
-2.33 %-46.40%
-4.34 %-39.59%
-7.19 %-19.82%
-8.97 %-39.46%
-14.81 %+199.98%
-4.94 %-31.14%
-7.17 %-48.00%
-13.79 %+34.97%
-10.22 %+85.82%
-5.50 %+817.08%
-0.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

StimCell Enegetics Stock analysis

What does StimCell Enegetics do? Cell MedX Corp. makes money through its subsidiary Avyonce Cosmedics Inc., which resells spa technology and equipment to the beauty and wellness industry. Avyonce also markets eBalance Technology, used for micro current treatments targeting diabetes and related ailments, and conducts observational studies with this technology. The company provides continuing education for estheticians and healthcare professionals in medical aesthetics. Avyonce Cosmedics Inc. serves the beauty and wellness industry, focusing on professionals who use spa technology and equipment. The firm develops a family of devices based on eBalance Technology, which is applied in treatments for diabetes and related conditions. This technology is central to Avyonce's product offerings and educational services. Cell MedX Corp. operates as a development stage company with no full-time employees, relying on its subsidiary Avyonce to drive revenue. The company's business model centers on the commercialization of eBalance Technology through product sales, educational programs, and observational studies in the medical aesthetics sector. StimCell Enegetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StimCell Enegetics stock

Free Cash Flow Yield of StimCell Enegetics is -4.98 % in 2026.

Free Cash Flow Yield of StimCell Enegetics changed from -2.26 % to -4.98 %, representing a 120.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield StimCell Enegetics since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's StimCell Enegetics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — StimCell Enegetics

All Key Metrics — StimCell Enegetics